一个定制的干预措施改善糖尿病视力障碍的成年人之间的自我照顾:试点研究
Hee Jung Kim1, Kyoung-Eun Lee2, Eunjin Yang3
1College of Nursing, Seoul National University, Seoul, South Korea.
Canadian journal of diabetes
|May 25, 2024
概括
一个定制的干预措施改善了糖尿病自我护理,自我有效性和视力受损的成年人的生活质量 (VI). 这些积极的结果在干预后两个月内持续存在,显示出对该人群中糖尿病管理的前景.
科学领域:
- 糖尿病自我护理研究 糖尿病自我护理研究
- 视力障碍研究的研究.
- 卫生干预发展 卫生干预发展
背景情况:
- 糖尿病自我护理对于管理这种疾病至关重要.
- 视力障碍 (VI) 患者在糖尿病自我护理方面面临着独特的挑战.
- 现有的干预措施可能无法充分满足VI患者的需求.
研究的目的:
- 开发和评估一个量身定制的干预措施 (TID-VI),以改善韩国成人VI型糖尿病患者的糖尿病自我护理.
- 评估TID-VI计划的可行性和初步影响.
- 调查干预对糖尿病自我效能,行为,心理健康,生活质量和临床结果的影响.
主要方法:
- 一个为期12周的量身定制干预 (TID-VI) 根据VI患者特定的障碍,资源和感知因素而设计.
- 一项单臂试点研究涉及14名VI患者.
- 测量包括糖尿病自我有效性,自我护理行为,抑郁,生活质量,禁食血糖,A1C,脂质和血压,评估干预前后 (长达2个月).
主要成果:
- 所有14名参与者都完成了TID-VI计划.
- 从基线看,糖尿病自我有效性,糖尿病自我护理行为,抑郁症和与健康有关的生活质量有显著的改善,持续2个月.
- 高密度和低密度脂蛋白水平有所改善,但在血糖,A1C,总胆固醇或血压方面没有发现显著变化.
结论:
- 基于理论的,量身定制的干预 (TID-VI) 可以显著改善患者报告的VI成年人的生活质量和健康状况.
- 这项干预措施对提高糖尿病自我护理和相关结果在这个人群中充满希望.
- 需要进一步的受控研究来证实这些初步发现.
相关概念视频
Diabetes: Management and Pharmacotherapy
265
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265
Diabetes: Symptoms, Diagnosis, and Complications
524
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
524
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84


